Large-scale iPSC production system aimed at clinical therapy funded by NIH
Allele Biotechnology and Pharmaceuticals (San Diego, CA, USA) has been awarded a Phase I SBIR grant by the NIH’s NHLBI to support the development of a large-scale, clinical-grade induced pluripotent stem cell manufacturing system aimed at producing stem cell-derived cells and tissues for clinical application.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>